$CCJ

Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom

Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.

Original reporting
Published Sep 7, 2026, 10:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 7, 2026, 10:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom — source image
Decision brief

The 30-second read

$CCJBullishMed
01

Why it matters

Analyst initiation and target upgrades provide fresh, material information that can influence trading decisions for CCJ and BWXT.

02

Market read

First‑time analyst coverage of two nuclear‑energy firms introduces actionable upside potential for traders.

03

What to watch

Execution risk on the Army micro‑reactor program could delay BWXT's revenue upside.

Relevance 7/10Novelty 8/10Timing: post‑coverage release Sep 3

Background

Jefferies turned bullish on the nuclear sector, initiating coverage of two U.S. listed companies with new price targets.

Company-level read

Ticker impact

$CCJBullishHigh confidence
Context

Jefferies initiated coverage of Cameco (CCJ) with a Buy rating and a $138 price target, implying over 31% upside.

Expected impact

Potential upside of 30%+ if target is reached; short-term rally likely.

Evidence & confidence

Coverage initiation is a primary catalyst; Jefferies' bullish stance may attract institutional interest.

$BWXTBullishHigh confidence
Context

Jefferies initiated coverage of BWX Technologies (BWXT) with a Buy rating and a $181 price target, implying about 13% upside.

Expected impact

Expect modest upside of 10‑15% as investors price in the new target.

Evidence & confidence

Analyst coverage combined with a disclosed $2.2 bn Army contract provides a concrete growth catalyst.

Market effects

The bullish stance may lift other uranium miners and nuclear‑reactor suppliers as the sector gains visibility.

U.S. nuclear‑technology stocks could see increased demand from investors tracking policy‑driven growth.

International nuclear‑energy players may benefit from heightened investor focus on the global nuclear build‑out.

Counterpoint

If uranium prices remain weak, Cameco's upside could be limited despite the coverage.

Key entities

  • Cameco Corporation

    Uranium miner with a new Buy rating and $138 price target.

  • BWX Technologies, Inc.

    Nuclear reactor supplier with a new Buy rating and $181 price target.

Related articles

$BWXTHighAI 8/10

BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock?

BWX Technologies (NYSE: BWXT) is the lowest-valued nuclear stock despite its monopoly in supplying nuclear reactors and fuel to the U.S. Navy. Its Q2 revenue rose 18% YoY to $901.6M, with EPS up 5% to $1.07. The company has an $8.6B backlog and raised its yearly revenue guidance to $3.8B. BWX also expanded into commercial markets, with Q2 commercial revenue up 72% YoY to $303M.

$BWXTMed

Expansion of Commercial Operations in Focus for BWX Technologies (BWXT)

Wells Fargo upgraded BWX Technologies (BWXT) to Equal Weight, lowering its target price to $170. The company reported Q2 2026 revenue of $901.6M, up from $764M last year, with adjusted EPS of $1.07. BWXT raised its full-year revenue guidance to $3.8B and adjusted EPS guidance to $4.70-$4.80. The stock is down 11.89% year-to-date. Management highlighted growth in commercial operations, while analysts noted risks related to revenue mix and leverage.

$CCJMedAI 8/10

TSX:CCO Stock Outlook: Cigar Lake Restart, Westinghouse IPO and India Deal Strengthen Cameco’s Nuclear Story

Cameco (TSX:CCO), a major uranium producer, reported Q2 2026 revenue of C$814M and adjusted EBITDA of C$391M. The company restarted Cigar Lake mine, increased its ownership to 57.418%, and secured a US$2.6B uranium supply deal with India. Westinghouse, in which Cameco has a stake, filed for an IPO. Cameco's stock was trading around C$138.65 as of September 4, 2026.

$DRSMedAI 8/10

Q2 Earnings Highs And Lows: Leonardo DRS (NASDAQ:DRS) Vs The Rest Of The Defense Contractors Stocks

Parsons (PSN) reported flat Q2 revenue of $1.58B, missing estimates, and lowered full-year guidance, causing its stock to drop 26.3%. BWX (BWXT) reported $901.6M revenue, up 18%, meeting expectations and beating EBITDA guidance. RTX (RTX) reported $24.71B revenue, up 14.5%, beating expectations and raising EPS guidance. The stock is up 3.2% since reporting.

$CCJHigh

Jefferies Gives Cameco (CCJ) Stock a Buy Rating With $138 Price Target

Jefferies initiated coverage of Cameco (CCJ) with a Buy rating and $138 price target, citing its leadership in uranium supply and nuclear energy demand. Shares rose 3.4% on the news. Wellington Management disclosed a new 2.09M share position. Q2 earnings of $0.13 per share missed estimates. Analysts maintain a Moderate Buy consensus with a $145.68 average target.